iShares Nasdaq Biotechnology ETF (IBB)
| 252.08 Real-Time Quote |  -1.98 / -0.78%Today’s Change | 187.05 Today|||52-Week Range 275.40 | +11.02% Year-to-Date |
Investment Objective
The investment seeks to track the investment results of an index composed of biotechnology and pharmaceutical equities listed on the NASDAQ. The fund generally invests at least 90% of its assets in securities of the underlying index and in depositary receipts representing securities of the underlying index. The underlying index contains securities of NASDAQ ® listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals and that also meet other eligibility criteria determined by the NASDAQ OMX Group, Inc. The fund is non-diversified.
Latest IBB News
| Health Care Select Is Among This Yearo?=o?=o?=s Hottest Health Care ETFs Jul 24 / TheStreet.com | Are Biotechs Overvalued? Jul 21 / MotleyFool.com |
| Invest In These Alternatives To Biotech Jul 23 / Investing Channel | The Fed's Valuation Concerns Put These Growth ETFs in Focus - ETF News And Commentary Jul 17 / Zacks.com |
| Stocks With Shaky Valuations? Jul 22 / Investing Channel | Fed: These Two Industries Look Overvalued - Real Time Insight Jul 15 / Zacks.com |
Performance
| 1 month | -0.57% | 3 years | +33.66% | |
| 3 months | +13.69% | 5 years | +27.08% | |
| 1 year | +30.32% | Since inception | +7.34% |
Data through 07/26/2014
Quote Details
| Previous close | $254.06 |
| Open day’s range | 249.94 – 254.06 |
| Net asset value (NAV) | 254.39 (07/25/2014) |
| Daily volume | 707,435 |
| Average volume (3 months) | 1,283,062 |
Data as of 2:01pm ET, 07/28/2014
Peer Comparisonvs. Health ETFs
| IBB | Category | |
|---|---|---|
| Performance 5-yr return | +27.08% | +24.14% |
| Expense Gross exp ratio | 0.48% | 0.43% |
| Risk 5 year sharpe ratio | 1.47 | 1.52 |
| Net assets | $5.3B | $1.4B |
| Average market cap | $14.8B | $25.9B |
| Average P/E | 34.9 | 26.1 |
| Dividend / Share | -- | 0.21% |
Competitors
| VHT Vanguard Health Care ETF |
| XLV Health Care Select Sector SPDR® Fund |
| IXJ iShares Global Healthcare ETF |
Holdings
Top 5 SectorsPortfolio weighting
| Healthcare | 99.91% |
| Business service | 0.09% |
| Consumer goods | 0.00% |
| Consumer service | 0.00% |
| Energy | 0.00% |
Top 10 HoldingsPortfolio weighting
| CELG Celgene Corp | 8.36% |
| AMGN Amgen Inc | 7.60% |
| GILD Gilead Sciences Inc | 7.60% |
| BIIB Biogen Idec Inc | 7.35% |
| ALXN Alexion Pharmaceuticals Inc | 6.39% |
| VRTX Vertex Pharmaceuticals Inc | 4.88% |
| ILMN Illumina Inc | 4.20% |
| MYL Mylan Inc | 3.85% |
| REGN Regeneron Pharmaceuticals Inc | 3.43% |
| ENDP Endo International PLC | 2.38% |
.
